Ligne de temps
Anastasia V. Komarova
Chercheur(euse) Permanent(e)
07 oct. 2024
publication
Profiling Cullin4-E3 ligases interactomes and their rewiring in influenza A virus infection.
Lire plus09 mars 2024
publication
Comparative analysis of rabies pathogenic and vaccine strains detection by RIG-I-like receptors.
Lire plus05 févr. 2024
01 janv. 2024
30 sept. 2023
11 mars 2023
publication
Rapid protection induced by a single-shot Lassa vaccine in male cynomolgus monkeys.
Lire plus01 févr. 2023
publication
Antagonism of ALAS1 by the Measles Virus V protein contributes to degradation of the mitochondrial network and promotes interferon response.
Lire plus18 janv. 2023
15 juil. 2022
publication
Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1.
Lire plus01 mars 2022
publication
sgDI-tector: defective interfering viral genome bioinformatics for detection of coronavirus subgenomic RNAs.
Lire plus14 déc. 2021
01 déc. 2021
publication
A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters.
Lire plus22 oct. 2021
publication
A recombinant measles virus vaccine strongly reduces SHIV viremia and virus reservoir establishment in macaques.
Lire plus09 juin 2021
publication
A single-shot Lassa vaccine induces long-term immunity and protects cynomolgus monkeys against heterologous strains.
Lire plus27 janv. 2021
publication
Proteomic Analysis Uncovers Measles Virus Protein C Interaction With p65-iASPP Protein Complex.
Lire plus13 janv. 2020
publication
Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus.
Lire plus11 déc. 2019
publication
An RNA-Binding Protein Secreted by a Bacterial Pathogen Modulates RIG-I Signaling.
Lire plus01 oct. 2019
01 avr. 2019
publication
Strong antigen-specific T-cell immunity induced by a recombinant human TERT measles virus vaccine and amplified by a DNA/viral vector prime boost in IFNAR/CD46 mice.
Lire plus01 avr. 2019
publication
Measles-vectored vaccine approaches against viral infections: a focus on Chikungunya.
Lire plus01 janv. 2019
publication
Recombinant measles vaccine expressing malaria antigens induces long-term memory and protection in mice.
Lire plus01 oct. 2018
publication
DI-tector: defective interfering viral genomes’ detector for next-generation sequencing data.
Lire plus10 juil. 2018
10 juil. 2018
15 oct. 2017
publication
Nonencapsidated 5′ Copy-Back Defective Interfering Genomes Produced by Recombinant Measles Viruses Are Recognized by RIG-I and LGP2 but Not MDA5.
Lire plus24 mars 2016
publication
Comparative analysis of viral RNA signatures on different RIG-I-like receptors.
Lire plus14 sept. 2015
02 mars 2015
publication
Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial.
Lire plus05 mai 2014
publication
High-throughput screening for broad-spectrum chemical inhibitors of RNA viruses
Lire plus04 juin 2013
publication
A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus.
Lire plus01 avr. 2013
12 sept. 2011
publication
Proteomic analysis of virus-host interactions in an infectious context using recombinant viruses.
Lire plus18 sept. 2009
publication
Differential regulation of type I interferon and epidermal growth factor pathways by a human Respirovirus virulence factor
Lire plus01 janv. 2009
19 nov. 2008
publication
mRNA translation regulation by the Gly-Ala repeat of Epstein-Barr virus nuclear antigen 1
Lire plus07 févr. 2007
publication
Rabies virus matrix protein interplay with eIF3, new insights into rabies virus pathogenesis
Lire plus13 oct. 2006
15 août 2006
publication
Effects of the Sabin-like mutations in domain V of the internal ribosome entry segment on translational efficiency of the Coxsackievirus B3
Lire plus01 janv. 2006
publication
The case for mRNA 5′ and 3′ end cross talk during translation in a eukaryotic cell
Lire plus01 sept. 2005
publication
[An Escherichia coli strain producing a leaderless mRNA from the chromosomal lac promoter]
Lire plus01 févr. 2005
publication
AU-rich sequences within 5′ untranslated leaders enhance translation and stabilize mRNA in Escherichia coli
Lire plus01 déc. 2003
publication
A key role for the mRNA leader structure in translational control of ribosomal protein S1 synthesis in gamma-proteobacteria
Lire plus01 sept. 2002
publication
Protein S1 counteracts the inhibitory effect of the extended Shine-Dalgarno sequence on translation
Lire plus01 juil. 2001
publication